跳至主要内容
临床试验/CTRI/2025/10/096224
CTRI/2025/10/096224招募中3 期

Study the Efficacy of Shankhapushpi (Convolvulus pluricaulis) Siddha Taila Shiroabhyanga on Mentally Stressed College Going Students.

Dr Nikita Rikame1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
32
试验地点
1
主要终点
Relief from symptoms of Nidranasha, Mental stress and Anxiety as indicated by post-intervention scores on PSQI, PSS, and HAM-A.

研究概览

简要总结

Shankhpushpi has been recognized in Ayurveda as ‘Medhya Rasayana’ meaning a drug which rejuvenates, maintains and potentiates intellect and memory**.**Shankhpushpi’s isolated compounds have also demonstrated therapeutic potential in pertaining to anti-depressants CNS depression, calmative, anti-oxidant, anti-amnesic properties & antistress activity. Convolvulus pluricaulis possess several neuropharmacological properties including nootropic, neuroprotective, anti- depressant, anti-stress, anti-inflammatory, anti-oxidant, anti- convulsant, anxiolytic, sedative, anti-Alzheimer’s, anti- Parkionson’s.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 25.00 Year(s)(—)
性别
All

入选标准

  • 1.Participants with a Pittsburgh Sleep Quality Index total score between 5 and 21 2.Participants with a Perceived Stress Scale score ranging from 0 to 26 3.Those willing to perform Shiroabhyanga for 21 days will be recruited for trial.

排除标准

  • 1.Participants contra-indicated for Shiroabhyanga such as Ajeerna and Nava Jwara.
  • 2.Known case of Participants on anti-depressants, anxiolytic medications or sedatives, etc.
  • i.e., those suffering from severe Mental illness to avoid bias.
  • 3.Known case of head trauma.
  • 4.Known case of any systemic or metabolic disorders.
  • 5.Participants undergoing detox treatment for addiction.

结局指标

主要结局

Relief from symptoms of Nidranasha, Mental stress and Anxiety as indicated by post-intervention scores on PSQI, PSS, and HAM-A.

时间窗: basline, 7th and 14th day

次要结局

  • Relief from symptoms of Nidranasha, Mental stress and Anxiety as indicated by post-(basline and 21st day)

研究者

发起方
Dr Nikita Rikame
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Nikita Rajkumar Rikame

Bharati Vidyapeeth Deemed to be University college of Ayurved Pune

研究点 (1)

Loading locations...

相似试验